Table 3 Survival for HHD patients and matched IHD and PD patients
Overall survival | |||
With censoring only at end of study | |||
HHD | IHD | PD | |
Median (IQR) years | 18.5 (10.4-NAa) | 11.9 (3.8- NAa) | 15.0 (5.1- NAa) |
Comparison with HHD (p value) | – | < 0.001 | 0.002 |
Mean years | 16.6 | 12.5 | 13.8 |
With censoring at end of study and recovered native renal function | |||
HHD | IHD | PD | |
Median (IQR) years | 18.5 (10.4- NAa) | 12.0 (3.8- NAa) | 15.1 (5.1- NAa) |
Comparison with HHD (p value) | – | < 0.001 | 0.003 |
Mean years | 16.5 | 12.6 | 13.9 |
Survival on initial RRT only | |||
With censoring at all changes from the initial modality | |||
HHD | IHD | PD | |
Median (IQR) years | NAb (8.4-NA) | 6.3 (2.9–11.5) | 6.1 (3.2–6.6) |
Comparison with HHD (p value) | – | < 0.001 | < 0.001 |
Mean years | 9.8 | 8.2 | 7.3 |
Survival on dialysis treatment only | |||
With censoring at renal transplantation, recovered native renal function and end of study | |||
HHD | IHD | PD | |
Median (IQR) years | 8.4 (6.7–10.7) | 6.2 (2.9–11.4) | 5.2 (3.1–7.5) |
Comparison with HHD (p value) | – | 0.001 | < 0.001 |
Mean years | 8.1 | 8.0 | 6.4 |